Table 1.
Clinical characteristics.
| Histologically analyzed (N = 91) | |
|---|---|
| Characteristic | |
| Age on admission (y), median (range) | 70.4 (53-91) |
| Women, n (%) | 44 (48.3%) |
| Interventional parameters | |
| TICI score; n (%) | |
| 0-2a | 7 (7.6%) |
| 2b-3 | 84 (92.4%) |
| Bridging therapy, n (%) | 50 (54.9%) |
| Occlusion site | |
| Anterior circulation | 67 (73.6%) |
| Posterior circulation | 24 (26.4%) |
| TOAST, n (%) | |
| Atherosclerosis | 31 (34%) |
| Cardioembolic | 56 (61.5%) |
| Other cause | 4 (4.5%) |
| Vascular risk factors, n (%) | |
| Hypertension | 63 (69.2%) |
| Diabetes mellitus | 18 (19.8%) |
| Coronary heart disease | 19 (20.9%) |
| Hemorrhagic transformation, n (%) | 32 (35.2%) |
| Clinical outcome, n (%) | |
| mRS (0-2) | 52 (57.2%) |
| mRS (3–6) | 39 (42.8%) |
| Mortality | 15 (16.5%) |
TICI: thrombolysis in cerebral infarction; TOAST: Trial of Org 10172 in Acute Stroke Treatment; mRS: modified Rankin Scale.